The Curbsiders Internal Medicine Podcast cover image

#329 Curing Hepatitis C: A Primary Care Primer

The Curbsiders Internal Medicine Podcast

00:00

Is on Treatment Monitoring Necessary?

The good news on side effects is they are not very common. I usually say ten to 15 % of people in the clinical trials will have something general like nausea, headache or fatigue. If you haven't identified rena failure, or a h v co infection, or heptetes b co infection, and we haven't in our case here, you don't need to check labs at all. There's one thing i want to just drop as a pearl here, which is this, this particular patient, i think you mentione, was obese. So maybe end of treatment, om anacend another set of labs, just maybe that metabolic panel. And what i'm doing there

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app